Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations ; volume:9 ; number:1 ; day:30 ; month:7 ; year:2010 ; pages:1-13 ; date:12.2010
Molecular cancer ; 9, Heft 1 (30.7.2010), 1-13, 12.2010
- Creator
-
Bavi, Prashant
Prabhakaran, Sarita E.
Abubaker, Jehad
Qadri, Zeeshan
George, Thara
Al-Sanea, Nasser
Abduljabbar, Alaa
Ashari, Luai H.
Alhomoud, Samar
Al-Dayel, Fouad
Hussain, Azhar R.
Uddin, Shahab
Al-Kuraya, Khawla S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-203
- URN
-
urn:nbn:de:101:1-2021082819231402338344
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bavi, Prashant
- Prabhakaran, Sarita E.
- Abubaker, Jehad
- Qadri, Zeeshan
- George, Thara
- Al-Sanea, Nasser
- Abduljabbar, Alaa
- Ashari, Luai H.
- Alhomoud, Samar
- Al-Dayel, Fouad
- Hussain, Azhar R.
- Uddin, Shahab
- Al-Kuraya, Khawla S.
- SpringerLink (Online service)
Other Objects (12)
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
ALK alterations in salivary gland carcinomas
KRAS mutations in squamous cell carcinomas of the lung
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Mitochondrial alterations in solid carcinomas : relationship between tumorgenesis of human kidney carcinomas and mitochondrial DNA (mtDNA) alterations
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
ALK alterations in salivary gland carcinomas
KRAS mutations in squamous cell carcinomas of the lung
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Mitochondrial alterations in solid carcinomas : relationship between tumorgenesis of human kidney carcinomas and mitochondrial DNA (mtDNA) alterations
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
ALK alterations in salivary gland carcinomas
KRAS mutations in squamous cell carcinomas of the lung
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis